Diabetes Prevalence in Dallas – 7.1% of the adult population is diagnosed with diabetes

o        Whites: 47,425

o        Blacks: 30,319

o        Hispanics: 35,824

Data Source – Texas Department of State Health Services, Texas Vital Statistics.

Statewide stats

o        In 2005, 1.3 million people were diagnosed with diabetes in the state of Texas

o        64% of adults in Texas diagnosed with diabetes suffer from one poor day of mental health or physical health per month

Data Source – Centers for Disease Control and Prevention. Available online at: http://www.cdc.gov/diabetes/statistics/prev/state/source.htm

You can find animated video of the i-port and patient testimonials at www.pattonmd.com, and I can also send a product sample for your review.  

ABOUT i-port®

The i-port® Injection Port is a discreet injection delivery device used in conjunction with a syringe or pen that allows for multiple daily injections without repeated skin punctures. 

The i-port® aims to improve the health and quality of life of individuals taking injectable medications, including insulin, and is an ideal treatment delivery tool for any individual who struggles with the hardships associated with daily injections.

More specifically, the i-port® is a practical treatment option for adults with diabetes who:

• Are newly diagnosed as insulin dependent
• Currently take daily injections of insulin and/or other medications
• Want a “vacation” from the insulin pump or those on a pump taking adjunctive injectable medication
• Would benefit from replacing their oral medication with an injectable medication
• Would benefit from adding an injectable medication to their current treatment regimen

The i-port® reduces the emotional, psychological and physical discomforts of standard injections by providing both adults and children a simple way to administer prescribed medications without the repeated skin punctures.

Using the i-port® could reduce the total number of skin punctures each month from 120 or more to as few as 10. For many individuals, the device may help reduce bruising and scar tissue, minimize injection site preparation time, increase management of glucose levels during mealtime, and provide enhanced lifestyle flexibility. Providing this benefit can encourage greater compliance with a treatment regimen and result in fewer complications.

INDICATION

The i-port® is indicated for use by people requiring multiple daily, subcutaneous injections of physician-prescribed medications, including insulin.  The i-port® can be worn for up to 72 hours while swimming, bathing or exercising, and is only 1.5” in diameter (38mm), 1/3” (9mm) in height. The i-port® is suitable for adults, and can also be used in healthcare facilities by caretakers administering prescribed medication to their patients.

People applying the i-port® for the first time should do so in the presence of a healthcare professional. 

HOW IT WORKS

When applying the i-port®, an insertion needle guides a soft cannula (a small, flexible tube) under the skin in to the subcutaneous tissue (the tissue layer located just beneath the skin.  Once applied, the insertion needle is removed and only the soft cannula remains.

When injecting into the i-port®, a syringe or insulin pen is inserted into the septum located on the top of the device. The needle of the syringe or pen remains above the surface of the skin, and the device functions as a gateway, allowing for direct insulin delivery from the injection, into the subcutaneous tissue.

The i-port® can accommodate 75 injections, and be worn for up to 72 hours.

ABOUT KK PATTON

Catherine (KK) Patton was diagnosed with gestational diabetes at the age of 30 while pregnant with her son Will.  As a result of her diagnosis, KK was immediately forced to take insulin injections four times per day to control her disease.  Although KK’s team of healthcare providers expected her diabetes to be a temporary case, she continued to experience symptoms post-pregnancy.  Finally, after significant weight loss and overwhelming fatigue, KK was diagnosed with Type 1 diabetes, at a critical point when her body was no longer able to produce insulin.  She was forced to continue taking insulin injections to quickly and effectively control blood glucose levels and prevent possible complications.

Although KK did not have a fear of needles, she did fear the pain and bruising caused by puncturing her skin.  Additionally, KK quickly became overwhelmed by the number of times per day she required an insulin shot.  KK knew she was not alone in her struggle with diabetes and that an unmet need existed to help patients achieve compliance with their insulin injections, and improve quality of life. 

After speaking with thought leaders, her diabetes educator and other patients, KK invented the i-port ®, an injection port designed to reduce the impact of injections by reducing the number of skin punctures from four to six times per day to just one every three days.  Armed with her new technology and motivation to make a difference in the lives of people with injectable insulin-dependent diabetes, she founded Patton Medical Devices in 2004.  In 2005, the FDA cleared the i-port ®,device developed by KK and Patton Medical Devices.  Today, the i-port ®, is available throughout the United States.

Today, KK and Patton Medical Devices are continuing to develop i-port ®, for people living with insulin requiring diabetes.  Patton Medical Devices is currently conducting clinical trials to further support the medical need for i-port ®,and explore additional indications.  Additionally, Patton Medical Devices is heavily involved in the diabetes community supporting organizations like the American Diabetes Association and the American Association of Diabetes Educators.